[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:il6-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"IL6 Gene",7,6,[8,16,22,28,34,40,47],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06775964","Stem Cell Therapy for Early Alzheimer's Disease",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:01.714035Z","2026-05-05T02:43:27.929167Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT03836482","Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD",[],"2026-08-26T02:16:27.227548Z","2026-05-05T02:43:26.951562Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07425587","Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study",[],"2026-08-26T02:18:53.782384Z","2026-07-05T03:45:20.251294Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT06269653","Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide",[],"2026-08-26T02:18:26.129155Z","2026-05-13T02:55:06.431175Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT07693140","Low-Dose Radiotherapy for Alzheimer's Disease",[12],"2026-08-26T02:16:49.565137Z","2026-07-19T19:36:05.157476Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":45,"content_modified":46},"NCT05485961","Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)",[44],"Phase 2\u002FPhase 3","2026-08-26T02:17:00.709807Z","2026-07-19T19:36:05.116191Z",{"nct_id":48,"title":49,"phases":50,"status":52,"updated_at":53,"content_modified":54},"NCT07708038","Anti-Interleukin-6 (IL6) in Calciphylaxis",[51],"Phase 1","NOT_YET_RECRUITING","2026-08-26T02:16:33.772093Z","2026-07-19T19:36:05.091392Z"]